CLINICAL_TRIALS
trial_result
· 2014-10-27
Clinical Trial Update: Absolute Bioavailability, Safety, and Tolerability of Subcutaneous GS-5745 in Healthy Adults [Phase 1]
Summary
Phase 1 study assessing the absolute bioavailability, safety, and tolerability of subcutaneous GS-5745 in healthy adults. Ulcerative Colitis is listed as a tria…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Gilead Sciences | Conditions: Ulcerative Colitis | Phase 1 | Status: COMPLETED